Cogent Biosciences's total assets for Q2 2025 were $274.82M, a decrease of -3.16% from the previous quarter. COGT total liabilities were $119.78M for the fiscal quarter, a 84.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.